MDCG 2019-16 is intended to assist practitioners in compliance with the Medical Device Regulation and the In-Vitro Device Regulation. This paper presents a gap analysis of MDCG 2019-16, identifying key gaps and proposing a robust set of recommendations to enhance the IoMT regulatory framework. This work has been undertaken by a selection of current (2023-2025) projects, all funded under the Horizon Europe call “Enhancing cybersecurity of connected medical devices”: HORIZON-HLTH-2022-IND-13-01, and this paper summarises observations and recommendations from across these projects. There is considerable consensus across the projects in many recommendation themes, notably; linking cybersecurity with patient safety and privacy; keeping the guidelines current; and usage recipes for the guidelines. The paper also suggests toolkit solutions to address some of the recommendations.
The MedSecurance project focus on identifying new challenges in cyber security with focus on hardware and software medical devices in the context of emerging healthcare architectures. In addition, the project will review best practice and identify gaps in the guidance, particularly the guidance stipulated by the medical device regulation and directives. Finally, the project will develop comprehensive methodology and tooling for the engineering of trustworthy networks of inter-operating medical devices, that shall have security-for-safety by design, with a strategy for device certification and certifiable dynamic network composition, ensuring that patient safety is safeguarded from malicious cyber actors and technology “accidents”.
Digital health solutions hold promise for enhancing healthcare delivery and patient outcomes, primarily driven by advancements such as machine learning, artificial intelligence, and data science, which enable the development of integrated care systems. Techniques for generating synthetic data from real datasets are highly advanced and continually evolving. This paper aims to present the INSAFEDARE project’s ambition regarding medical devices’ regulation and how real and synthetic data can be used to check if devices are safe and effective. The project will consist of three pillars: a) assurance of new state-of-the-art technologies and approaches (such as synthetic data), which will support the validation methods as part of regulatory decision-making; b) technical and scientific, focusing on data-based safety assurance, as well as discovery, integration and use of datasets, and use of machine learning approaches; and c) delivery to practice, through co-production involving relevant stakeholders, dissemination and sustainability of the project’s outputs. Finally, INSAFEDARE will develop an open syllabus and training certification for health professionals focused on quality assurance.
Synthetic data utilization for model training in healthcare has grown in the last 15 years. However, there are several risks associated with this approach such as, privacy issues, where the patient’s data can be identifiable; data quality, where the complexity of the real-world scenarios is not captured; and ethical concerns, concerning malicious misuse. This paper highlights the challenges of using synthetic data by outlining the risks to contribute to developing more reliable, fair, and solutions.